At Diagnopein Nashik, this test plays a crucial role in ensuring safe blood transfusions, prenatal antibody screening, and diagnosing immune-mediated hemolytic anemia
Report Availability
24 hours
The Indirect Coombs Test (ICT), also known as the Indirect Antiglobulin Test (IAT), is an essential laboratory test used to detect antibodies in the blood serum that may react with red blood cells. Unlike the Direct Coombs Test, which identifies antibodies already attached to red blood cells, the Indirect Coombs Test detects free antibodies circulating in the bloodstream.
The Indirect Coombs Test is highly important for preventive healthcare and patient safety. Its key benefits include:
Blood Transfusion Safety: ICT helps identify pre-existing antibodies in patients, ensuring donor-recipient blood compatibility and preventing transfusion reactions.
Prenatal Screening: It detects maternal antibodies that could attack fetal red blood cells, reducing the risk of hemolytic disease of the newborn (HDN).
Immune Hemolytic Disorders Detection: Helps diagnose autoimmune hemolytic anemia, where the body attacks its own red blood cells.
Monitoring Drug-Induced Antibodies: Some medications can trigger antibody formation; ICT monitors this effectively.
At Diagnopein Nashik, our laboratory ensures precise results with minimal turnaround time, giving peace of mind to patients and doctors.
The Indirect Coombs Test offers several clinical and health benefits:
Early Detection of Antibodies: Detects antibodies before they cause complications in transfusions or pregnancy.
Safe Blood Transfusions: Minimizes acute and delayed transfusion reactions.
Guides Prenatal Care: Crucial for Rh-negative mothers to prevent fetal complications.
Supports Disease Management: Helps physicians plan targeted treatment for immune-related anemia.
Reliable and Accurate Results: At Diagnopein Nashik, advanced technology ensures trustworthy outcomes.
The test is performed in a step-by-step laboratory procedure:
Blood Sample Collection: Blood is drawn from the patient, usually from the arm vein.
Serum Separation: The sample is centrifuged to separate the serum containing antibodies.
Incubation with Donor Red Cells: Patient serum is mixed with red blood cells of known antigenicity.
Addition of Coombs Reagent: Anti-human globulin (Coombs reagent) is added to detect antibody binding.
Observation of Agglutination: Clumping of red cells indicates a positive result, confirming antibody presence.
Diagnopein Nashik ensures skilled technicians and modern equipment are used for accurate testing.
The Indirect Coombs Test measures:
Anti-Rh Antibodies: Detects antibodies responsible for Rh incompatibility in pregnancy.
Unexpected Alloantibodies: Formed due to blood transfusions or medications.
Antibody Titer Levels: Quantifies antibody concentration to assess severity.
These parameters help doctors make informed decisions regarding blood transfusions, pregnancy management, and anemia treatment.
The test is recommended for:
Pregnant Women: Especially Rh-negative mothers for antibody screening.
Patients Requiring Blood Transfusions: Ensures safe transfusions.
Individuals with Unexplained Anemia: Detects immune-related causes.
Patients on Certain Medications: Monitors drug-induced antibodies.
Diagnopein Nashik is the preferred choice for Indirect Coombs Test due to:
Certified Laboratory: Maintains highest quality standards.
Advanced Testing Equipment: Ensures accurate and fast results.
Experienced Team: Skilled technicians and pathologists.
Comprehensive Reports: Easy-to-understand reports for doctors and patients.
Affordable and Convenient Testing: Accessible healthcare solutions in Nashik.
1. Indirect coombs Test
2. Remark
This test detects unbound antibodies in the blood serum that can target RBCs, often used to determine blood compatibility for transfusions and assess Rh compatibility in pregnancy.
A positive result indicates the presence of RBC antibodies, which may require further testing or monitoring, especially in pregnancy or before a transfusion.
A negative result means no antibodies are detected against RBCs in the serum, indicating compatibility for transfusion or a lower risk of Rh incompatibility in pregnancy.
Diagnopein typically provides results within a few hours to a day, depending on the lab schedule and test load.
The test is recommended for Rh-negative mothers during pregnancy to monitor potential antibodies that may affect the fetus.
The indirect test examines unbound antibodies in serum, while the direct test detects antibodies bound to RBCs directly within the bloodstream.